A new study examined whether routine blood test measures could help in identifying disease flares in people with systemic ...

FT819 continues to demonstrate meaningful decrease in disease and favorable safety profile with twelve systemic lupus ...

Approval based on phase II NOBILITY and phase III REGENCY studies showing superiority of Gazyva/Gazyvaro over standard ...

Dermatologists long reluctant to tackle cutaneous lupus erythematosus may be more open to treating patients with approvals ...

Data show deep, durable responses in the 50 million cell dose level cohort; initial data suggest substantial early improvement in three patients dosed with 100 million cellsAll patients show deep ...

FT819 continues to demonstrate meaningful decrease in disease and favorable safety profile with twelve systemic lupus erythematosus (SLE) ...

Veterans with vs without SLE or RA had higher incidences of adverse pregnancy outcomes, including nonlive birth.

Self-care, structured exercise, and reliable medication adherence help stabilize systemic lupus erythematosus and reduce long ...

Lupus survivor and mother of one, Purity Nkatha, beats overwhelming odds to sit KCSE late, pass her NCK exams, and graduate ...

A common virus carried by most humans could trigger lupus, offering new clues for preventing and treating this dangerous ...

Roche has received EC approval for its humanised monoclonal antibody Gazyva, in combination with mycophenolate mofetil (MMF).

About 5 million people worldwide live with the autoimmune condition lupus. This condition can cause a range of symptoms, ...